Caracterización del dolor en pacientes con Enfermedad de Parkinson: Publicado originalmente en la revista Dor. São Paulo, 2014 apr-jun;15(2):78-82

Maria das Graças Wanderley de Sales Coriolano; Jenyffer Monnyk de Siqueira Balbino; Belvânia Ramos Ventura da Silva; Etenildo Dantas Cabral; Amdore Guescel Asano; Otávio Gomes Lins; Nadja Maria Jorge Asano

doi:10.47924/neurotarget2015214

Authors

Maria das Graças Wanderley de Sales Coriolano Universidad Federal de Pernambuco, Departamento de Anatomía, Recife, PE, Brasil.
Jenyffer Monnyk de Siqueira Balbino Universidad Federal de Pernambuco, Curso de Fisioterapia, Recife, PE, Brasil.
Belvânia Ramos Ventura da Silva Universidad Federal de Pernambuco, Curso de Fisioterapia, Recife, PE, Brasil.
Etenildo Dantas Cabral Universidad Federal de Pernambuco, Departamento de Anatomía, Recife, PE, Brasil.
Amdore Guescel Asano Universidad Federal de Pernambuco, Hospital de Clinicas, Programa Pro-Parkinson, Recife, PE, Brasil.
Otávio Gomes Lins Universidad Federal de Pernambuco, Departamento de Neuropsiquiatría, Recife, PE, Brazil.
Nadja Maria Jorge Asano Universidad Federal de Pernambuco, Departamento de Clínica Médica, Recife, PE, Brasil.

DOI:

https://doi.org/10.47924/neurotarget2015214

Keywords:

pain, pain measurement, Parkinson’s disease, sensory disorders

Abstract

Background and objectives. Pain in Parkinson’s disease is a very frequent complaint and may precede the diagnoses of the disease. This study aimed at evaluating pain in a group of Parkinson’s disease patients from a specialized treatment center.
Methods: This is a observational study of pain in Parkinson’s disease patients from the Clinicas Hospital, Federal University of Pernambuco. The convenience sample, obtained between July and August 2011, was made up of 24 individuals, being 17 males and 7 females, aged between 42 and 50 (mean=64.3) years, and 48 and 66 (mean=58.7) years, respectively. Section III of the Unified Parkinson’s Disease Rating Scale, Hoehn and Yahr (HY) scale according to the stage of the disease, McGill pain questionnaire and Mini Mental State Examination were used.
Results: Specific body region with most frequent pain was lumbar spine (50%). Categorized regions with highest complaint percentages were: trunk (66.7%) and limbs (37.5% upper; 37.5% lower). Most patients have referred pain in a single body region,
regardless of analyzing specific or categorized regions (37.5%). There has been no significant difference in proportional scores obtained by each McGill questionnaire score component. Patients with rigid-akinetic Parkinson’s disease had higher number of painful body regions. The comparison among McGill indices, according to predominant symptom and according to Parkinson’s disease stage (HY) scores has not shown significant differences.
Conclusion: In our study, all Parkinson’s disease patients have referred pain. Although pain is one of the most frequent non-motor symptoms, many aspects regarding Parkinson’s disease-related pain need further investigation, such as which would be the best pain categorization and which methodology could better distinguish different mechanisms of different types of pain.

Metrics

Metrics Loading ...

References

Charcot JM. Lectures on diseases of the nervous system. London: Ed. The New Sydenham Society; 1877. 1:137p.

Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP. Epidemiology of Parkinson’s disease. J Neurol. 2008;255(Suppl 5):18-32.

Letro GH, Quagliato EM, Viana MA. Pain in Parkinson’s disease. Arq Neuropsiquiatr. 2009;67(3-A):591-4.

Fil A, Cano-de-la-Cuerda R, Muñoz-Hellín E, Vela L, Ramiro-González M, Fernández- de-Las-Penãs C. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord. 2013;19(3):285-94.

Ciena AP, Gatto R, Pacini VC, Picanço VV, Magno IM, Alexan- dre E. Influência da intensidade da dor sobre as respostas nas escalas unidimensionais de mensuração da dor em uma popu- lação de idosos e de adultos jovens. Semina Cienc Biol Saúde. 2008;29(2):201-12.

Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1(3):277-99.

Folstein MF, Folstein SF, McHugh PR. „Mini-mental state“. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98.

Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 2001;57(10 Suppl 3):S11-26.

Fahn S, Elton RL. The unified Parkinson‘s disease rating scale. In: Fahn S, Masden CD, Calne DB, Goldstein M, (editors). Recent developments in Parkinson‘s disease. Florhan Park, NJ: Mac Millian Health Care Information; 1987. 293-304p.

Sage JL. Pain in Parkinson´s disease. Curr Treat Options Neurol. 2004;6(Suppl 3):191-200.

Wasner G, Deuschl G. Pains in Parkinson disease–many syndromes under one umbrella. Nat Rev Neurol. 2012;17(8):284-94.

Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinson’s disease: prevalence and characteristics. Pain. 2009;141(1-2):173-7.

Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, Moretto G, et al. Pain and motor complications in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006;77(7):822-5.

Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson’s disease. J Pain Symptom Manage. 2006;32(5):462-9.

Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson’s disease. Mov Disord. 1986;1(1):45-9.

Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson’s disease. Clin Neurol Neurosurg. 2011;113(1):11-3.

Martinez-Martin P, Falup Pecurariu C, Odin P, van Hilten JJ, An- tonini A, Rojo-Abuin JM, et al. Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease. J Neurol. 2012;259(8):1639-47.

Scott B, Borgman A, Engler H, Johnels B, Aquilonius SM. Gender differences in Parkinson’s disease symptom profile. Acta Neurol Scand. 2000;102(1):37-43.

Bernal SA, Morgan MM, Craft RM. PAG mu opioid receptor activation underlies sex differences in morphine antinociception. Behav Brain Res. 2007;177(1):126-33.

Dennis SG, Melzack R. Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests. Exp Neurol. 1983;81(1):167-76.

Zambito Marsala S, Tinazzi M, Vitaliani R, Recchia S, Fabris F, Marchini C, et al. Spontaneous pain, pain threshold, and pain toler- ance in Parkinson’s disease. J Neurol. 2011;258(4):627-33.

Schapira AH. Aetiopathogenesis of Parkinson’s disease. J Neurol. 2011;258(Suppl 2):S307-10.

Burkey AR, Carstens E, Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci. 1999;19(10):4169-79.

Hagelberg N, Jääskeläinen SK, Martikainen IK, Mansikka H, Forssell H, Scheinin H, et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Pharmacol. 2004;500(1-3):187-92.

Truini A, Frontoni M, Cruccu G. Parkinson’s disease related pain: a review of recent findings. J Neurol. 2013;260(1):330-4.

Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K. Parkinson´s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 2007;113(4):421-9.

Wasner G, Deuschl G. Pains in Parkinson disease--many syndromes under one umbrella. Nat Rev Neurol. 2012;8(5):284-94.

Broen MP, Braaksma MM, Patijn J, Weber WE. Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool. Mov Disord. 2012;27(4):480-4.